Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200063741Phase 2Not yet recruiting
Phase 2, randomised, double-blind trial of Shuhe granule in Insomnia (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Insomnia Severity Index total score. Planned start Jun 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200063741.